Analyst Articles

When it rains, it pours. And we’ll see how that bodes for the market as Wall Street is deluged with second-quarter earnings reports today, led by five Dow components during the day and culminating with results from Apple after the… Read More

“In the coming year, the Securities and Exchange Commission will complete its examination of the [nation’s rating agencies] role in rating residential mortgage-backed securities and collateralized debt obligations linked to subprime mortgage loans.” So said… Read More

Everything is relative, especially market valuation. A utility, for instance, with its steady, slow-growth business, is never going to command the earnings multiple of a rapidly growing biotech firm or high-tech upstart. That’s why it’s best to make valuation comparisons within industries. It’s also… Read More

Biogen Idec (Nasdaq: BIIB) said it earned $143 million in the second quarter, or 49 cents a share, down -31% from last year, when the company earned 70 cents a share. The results reflect a $110 million expenditure on Fampridine, a new drug to treat multiple sclerosis. Excluding the purchase,… Read More

ExxonMobil (NYSE: XOM) said it will spend $600 million to develop biofuel from algae. The petroleum giant, the most profitable company in the United States, will work in partnership with privately held Synthetic Genomics. Exxon will spend $300 million on its research and provide… Read More

Manufactured home builder Palm Harbor Homes (Nasdaq: PHHM) said it lost $10.0 million, or 44 cents a share, in its fiscal first quarter, compared with a loss of $0.5 million, or 2 cents a share, a year ago. Revenue fell -36.6%, to $82.4 million, from a year ago. The company… Read More

After looking at some of will have a better journey elsewhere. 10. Croatia With its long, beautiful coastline down the Adriatic Sea, tourism accounts for about 20% of the country’s GDP. The slowdown in that industry explains a big portion… Read More